<DOC>
	<DOCNO>NCT00043277</DOCNO>
	<brief_summary>The goal study : 1 . To assess safety bivalirudin infant six month arterial venous thrombosis ; 2 . To determine dose bivalirudin require achieve adequate anticoagulation measure activated clotting time ( ACT ) activate partial thromboplastin time ( aPTT ) Infants Under Six Months arterial venous thrombosis ; 3 . To determine outcome patient bivalirudin respect thrombus resolution bleed complication compare patient unfractionated heparin ( UH ) low molecular weight heparin ( LMWH ) .</brief_summary>
	<brief_title>Study Of Angiomax In Infants Under Six Months With Thrombosis</brief_title>
	<detailed_description>The goal study : 1 . To assess safety bivalirudin infant six month arterial venous thrombosis ; 2 . To determine dose bivalirudin require achieve adequate anticoagulation measure activated clotting time ( ACT ) activate partial thromboplastin time ( aPTT ) Infants Under Six Months arterial venous thrombosis ; 3 . To determine outcome patient bivalirudin respect thrombus resolution bleed complication compare patient unfractionated heparin ( UH ) low molecular weight heparin ( LMWH ) .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>Parent/legalguardian provide write informed consent initiation study related procedure . Objectively confirm thrombotic event either doppler ultrasound , echocardiogram , CT scan , MRI , MR angiogram , MR venogram , venogram arteriogram . Age le 6 month . Gestational age great 35 week Expected life expectancy least 14 day . No contraindication anticoagulation i.e . bleed complication . Active recent ( less 7 day ) bleeding . Known allergy Angiomax hirudin , know sensitivity component product . Participation clinical research study involve evaluation investigational drug device within 30 day enrollment . Refusal undergo blood transfusion become necessary . Any disease condition , , judgment Investigator would place patient undue risk enrol trial . Baseline prolong PT ( &gt; 18 sec ) aPTT ( &gt; 55 sec ) Platelet count &lt; 50,000 cells/mm3 Birth Trauma Planned indicate surgery within 30 day Major minor bleeding event</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>neonate</keyword>
	<keyword>thrombosis</keyword>
	<keyword>bivalirudin</keyword>
	<keyword>direct thrombin inhibitor</keyword>
</DOC>